📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
SCHOTT Pharma AG & Co KgaA
SCHOTT Pharma AG & Co's GHG Emissions Data Preview
In 2024, SCHOTT Pharma AG & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
SCHOTT Pharma AG & Co has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind SCHOTT Pharma AG & Co’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SCHOTT Pharma AG & Co’s data sources below and access millions more through our Disclosure Search.
Insights into SCHOTT Pharma AG & Co's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofSCHOTT Pharma AG & Co amounted to71,477metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Codecreased by 3.16%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
SCHOTT Pharma AG & Co's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 1 emissions?
In 2024, the total Scope 1 emissions of SCHOTT Pharma AG & Co were 27,536 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2023), SCHOTT Pharma AG & Co's Scope 1 emissions decreased by 8.9%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are SCHOTT Pharma AG & Co's Scope 2 emissions?
In 2024, SCHOTT Pharma AG & Co reported Scope 2 greenhouse gas (GHG) emissions of 60 tCOâ‚‚e using the market-based method and 43,941 tCOâ‚‚e using the location-based method.a
Has SCHOTT Pharma AG & Co reduced its Scope 2 emissions over time?
Compared to the previous year(2023), SCHOTT Pharma AG & Co's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does SCHOTT Pharma AG & Co use for Scope 2 reporting?
In 2024, SCHOTT Pharma AG & Co reported its Scope 2 emissions using the market-based method and using the location-based method.a
SCHOTT Pharma AG & Co's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into SCHOTT Pharma AG & Co's Value Chain Emissions
In 2024, SCHOTT Pharma AG & Co reported 398,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of SCHOTT Pharma AG & Co includes a breakdown across 5of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
SCHOTT Pharma AG & Co's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2024, SCHOTT Pharma AG & Co reported total Scope 3 emissions of 398,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 90.32%of these emissions originated from upstream activities such as purchased goods and capital goods, while 9.68%came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), SCHOTT Pharma AG & Co's Scope 3 emissions remained relatively stable, indicating that SCHOTT Pharma AG & Co's emissions have plateaued with no significant change in its value chain footprint.a
What categories of Scope 3 emissions does SCHOTT Pharma AG & Co disclose?
In 2024, SCHOTT Pharma AG & Co reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of SCHOTT Pharma AG & Co's Scope 3 emissions?
In 2024, the largest contributors to SCHOTT Pharma AG & Co's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 212,000 tCOâ‚‚e(68.39%)
- Capital Goods (Cat. 2): 48,000 tCOâ‚‚e(15.48%)
- Investments (Cat. 15): 30,000 tCOâ‚‚e(9.68%)
SCHOTT Pharma AG & Co's Scope 3 Emissions by Categories
Insights into SCHOTT Pharma AG & Co’s GHG Emissions Intensity Compared to Industry Peers
In 2024, SCHOTT Pharma AG & Co reported Scope 1 greenhouse gas (GHG) emissions of 27,536 tCOâ‚‚e and total revenues of USD 1,069 millions. This translates into an emissions intensity of 25.76 tCOâ‚‚e per millions USD.a
SCHOTT Pharma AG & Co's Scope 1 Emissions Intensity Compared to Peers
How does SCHOTT Pharma AG & Co's GHG emissions intensity compare to its peers?
In 2024, SCHOTT Pharma AG & Co reported a Scope 1 emissions intensity of 25.76 tCOâ‚‚e per millions USD. Compared to the peer group median of 4.48, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does SCHOTT Pharma AG & Co rank on GHG emissions intensity within its industry?
In 2024, SCHOTT Pharma AG & Co ranked 22 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places SCHOTT Pharma AG & Co among the least efficient performers, with one of the highest emissions intensities in its sector.a
Insights into SCHOTT Pharma AG & Co's Total Carbon Footprint
In 2024, SCHOTT Pharma AG & Co reported a total carbon footprint of 469,477 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.54% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to SCHOTT Pharma AG & Co's total carbon footprint was Scope 3 emissions, accounting for 84.78% of the company's total carbon footprint, followed by Scope 2 emissions at 9.36%.a